

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.49392148 |
| 2 | detection of other organism (GO:0098543) | 5.00970343 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.96594471 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.96594471 |
| 5 | detection of bacterium (GO:0016045) | 4.92179795 |
| 6 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.79118058 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.65225539 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.62657902 |
| 9 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.24195340 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.21116104 |
| 11 | detection of external biotic stimulus (GO:0098581) | 4.09954612 |
| 12 | leukocyte aggregation (GO:0070486) | 4.09669037 |
| 13 | positive regulation of B cell differentiation (GO:0045579) | 4.03187463 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 3.88257379 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 3.88257379 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.88257379 |
| 17 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.88257379 |
| 18 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.88257379 |
| 19 | modulation by symbiont of host immune response (GO:0052553) | 3.88257379 |
| 20 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.88167719 |
| 21 | negative regulation of phagocytosis (GO:0050765) | 3.86883038 |
| 22 | B cell receptor signaling pathway (GO:0050853) | 3.86844694 |
| 23 | regulation of B cell differentiation (GO:0045577) | 3.84584914 |
| 24 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.83761548 |
| 25 | regulation of gamma-delta T cell activation (GO:0046643) | 3.83723065 |
| 26 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.81682732 |
| 27 | negative regulation of T cell mediated immunity (GO:0002710) | 3.74832668 |
| 28 | T cell migration (GO:0072678) | 3.73067029 |
| 29 | negative regulation of cell killing (GO:0031342) | 3.67076379 |
| 30 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.67076379 |
| 31 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.66906361 |
| 32 | detection of molecule of bacterial origin (GO:0032490) | 3.63319325 |
| 33 | detection of biotic stimulus (GO:0009595) | 3.61908565 |
| 34 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.60754577 |
| 35 | neutrophil activation involved in immune response (GO:0002283) | 3.58905489 |
| 36 | immunoglobulin mediated immune response (GO:0016064) | 3.56626738 |
| 37 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.53352015 |
| 38 | interferon-gamma production (GO:0032609) | 3.52675032 |
| 39 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.51632201 |
| 40 | regulation of T cell tolerance induction (GO:0002664) | 3.47296284 |
| 41 | respiratory burst (GO:0045730) | 3.47009864 |
| 42 | response to host (GO:0075136) | 3.45601272 |
| 43 | microglial cell activation (GO:0001774) | 3.45029869 |
| 44 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.44772085 |
| 45 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.44394896 |
| 46 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.43244894 |
| 47 | response to peptidoglycan (GO:0032494) | 3.39085033 |
| 48 | tolerance induction (GO:0002507) | 3.36891981 |
| 49 | cellular extravasation (GO:0045123) | 3.36442374 |
| 50 | mature B cell differentiation (GO:0002335) | 3.34484172 |
| 51 | positive thymic T cell selection (GO:0045059) | 3.33589440 |
| 52 | regulation of leukocyte degranulation (GO:0043300) | 3.31889036 |
| 53 | regulation of tolerance induction (GO:0002643) | 3.31471776 |
| 54 | mast cell activation (GO:0045576) | 3.30994272 |
| 55 | neutrophil mediated immunity (GO:0002446) | 3.30947516 |
| 56 | macrophage activation (GO:0042116) | 3.29336051 |
| 57 | negative T cell selection (GO:0043383) | 3.29262145 |
| 58 | neutrophil activation (GO:0042119) | 3.29205408 |
| 59 | response to interleukin-15 (GO:0070672) | 3.27581075 |
| 60 | negative thymic T cell selection (GO:0045060) | 3.23697032 |
| 61 | defense response to protozoan (GO:0042832) | 3.20520772 |
| 62 | ribosomal small subunit assembly (GO:0000028) | 3.19032560 |
| 63 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.18208889 |
| 64 | myeloid dendritic cell activation (GO:0001773) | 3.17575285 |
| 65 | T cell homeostasis (GO:0043029) | 3.16963115 |
| 66 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.16219309 |
| 67 | response to protozoan (GO:0001562) | 3.15607739 |
| 68 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.14560911 |
| 69 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.14558084 |
| 70 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.11904612 |
| 71 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.11732539 |
| 72 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.11732539 |
| 73 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.09125103 |
| 74 | cellular response to interleukin-15 (GO:0071350) | 3.08945094 |
| 75 | positive regulation of antigen processing and presentation (GO:0002579) | 3.05693292 |
| 76 | granulocyte activation (GO:0036230) | 3.04875940 |
| 77 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.04196200 |
| 78 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.03817491 |
| 79 | negative regulation of innate immune response (GO:0045824) | 3.02626070 |
| 80 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.02516547 |
| 81 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.01580924 |
| 82 | negative regulation of interleukin-12 production (GO:0032695) | 3.00968922 |
| 83 | negative regulation of interleukin-6 production (GO:0032715) | 2.99699793 |
| 84 | mature B cell differentiation involved in immune response (GO:0002313) | 2.97513768 |
| 85 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.95704682 |
| 86 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.94478333 |
| 87 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.92954652 |
| 88 | negative regulation of type 2 immune response (GO:0002829) | 2.92443298 |
| 89 | activated T cell proliferation (GO:0050798) | 2.92299521 |
| 90 | lymphocyte homeostasis (GO:0002260) | 2.91870582 |
| 91 | response to type I interferon (GO:0034340) | 2.88596973 |
| 92 | B cell mediated immunity (GO:0019724) | 2.88405377 |
| 93 | myeloid cell activation involved in immune response (GO:0002275) | 2.84809289 |
| 94 | myeloid dendritic cell differentiation (GO:0043011) | 2.84633868 |
| 95 | cellular response to type I interferon (GO:0071357) | 2.84501031 |
| 96 | type I interferon signaling pathway (GO:0060337) | 2.84501031 |
| 97 | positive regulation of isotype switching (GO:0045830) | 2.83874033 |
| 98 | positive regulation of granulocyte differentiation (GO:0030854) | 2.83637523 |
| 99 | positive T cell selection (GO:0043368) | 2.82341760 |
| 100 | * antigen receptor-mediated signaling pathway (GO:0050851) | 2.81679071 |
| 101 | regulation of mast cell activation (GO:0033003) | 2.81559309 |
| 102 | megakaryocyte development (GO:0035855) | 2.80231961 |
| 103 | positive regulation of interferon-alpha production (GO:0032727) | 2.76402023 |
| 104 | regulation of antigen processing and presentation (GO:0002577) | 2.75897266 |
| 105 | response to muramyl dipeptide (GO:0032495) | 2.75866925 |
| 106 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.75849936 |
| 107 | mast cell activation involved in immune response (GO:0002279) | 2.75438553 |
| 108 | mast cell degranulation (GO:0043303) | 2.75438553 |
| 109 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.74890695 |
| 110 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.74784958 |
| 111 | response to host immune response (GO:0052572) | 2.74784958 |
| 112 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.74608768 |
| 113 | regulation of mast cell degranulation (GO:0043304) | 2.74384649 |
| 114 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.73791408 |
| 115 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.73615122 |
| 116 | cellular response to zinc ion (GO:0071294) | 2.73376725 |
| 117 | positive regulation of macrophage differentiation (GO:0045651) | 2.73051996 |
| 118 | leukocyte cell-cell adhesion (GO:0007159) | 2.72099223 |
| 119 | thymic T cell selection (GO:0045061) | 2.71667269 |
| 120 | T cell selection (GO:0045058) | 2.71369608 |
| 121 | definitive hemopoiesis (GO:0060216) | 2.70399924 |
| 122 | B cell homeostasis (GO:0001782) | 2.68029940 |
| 123 | positive regulation of mast cell activation (GO:0033005) | 2.66906999 |
| 124 | leukocyte degranulation (GO:0043299) | 2.66807818 |
| 125 | regulation of interferon-alpha production (GO:0032647) | 2.66767826 |
| 126 | NIK/NF-kappaB signaling (GO:0038061) | 2.66741311 |
| 127 | lymph node development (GO:0048535) | 2.64464233 |
| 128 | germinal center formation (GO:0002467) | 2.63014573 |
| 129 | macrophage activation involved in immune response (GO:0002281) | 2.62002298 |
| 130 | leukocyte homeostasis (GO:0001776) | 2.59229718 |
| 131 | actin nucleation (GO:0045010) | 2.59096165 |
| 132 | natural killer cell activation (GO:0030101) | 2.58937810 |
| 133 | positive regulation of interleukin-2 production (GO:0032743) | 2.57754880 |
| 134 | response to host defenses (GO:0052200) | 2.55420277 |
| 135 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.55420277 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.67885871 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.52138495 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.92459320 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.88189610 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.72158071 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.67612147 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.65343959 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.64958480 |
| 9 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.20486327 |
| 10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.12185772 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.96236969 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.79965417 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.78224014 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.76511030 |
| 15 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.75800645 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.64951068 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.57814706 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.56129627 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.54826273 |
| 20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.54428871 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.53292140 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.49676301 |
| 23 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.46881448 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 2.45763647 |
| 25 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.33685559 |
| 26 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.32111885 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 2.26046061 |
| 28 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.23009217 |
| 29 | MYB_26560356_Chip-Seq_TH1_Human | 2.20468104 |
| 30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.20125289 |
| 31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.10245500 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.10187196 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.09948891 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 2.00515140 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.98028375 |
| 36 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96496766 |
| 37 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.96073930 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91738432 |
| 39 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.91557041 |
| 40 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.91427025 |
| 41 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89295890 |
| 42 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.76591307 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.71609599 |
| 44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.69394472 |
| 45 | SPI1_23127762_ChIP-Seq_K562_Human | 1.63900032 |
| 46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.63182058 |
| 47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.62405600 |
| 48 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.61946873 |
| 49 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.59099588 |
| 50 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.59067483 |
| 51 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.56666088 |
| 52 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.54770875 |
| 53 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.52154702 |
| 54 | MAF_26560356_Chip-Seq_TH2_Human | 1.50252378 |
| 55 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.49838811 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.49033547 |
| 57 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.47273887 |
| 58 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46315380 |
| 59 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.40963932 |
| 60 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.39235480 |
| 61 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.38380136 |
| 62 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.38161518 |
| 63 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.32989165 |
| 64 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.31290713 |
| 65 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30414601 |
| 66 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.26419920 |
| 67 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.25017201 |
| 68 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.24679878 |
| 69 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.23165582 |
| 70 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22746331 |
| 71 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22524088 |
| 72 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22479121 |
| 73 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21923161 |
| 74 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.21368906 |
| 75 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.19262125 |
| 76 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.19035199 |
| 77 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18857251 |
| 78 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.16677662 |
| 79 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16527341 |
| 80 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.16445077 |
| 81 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15627176 |
| 82 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.14009334 |
| 83 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12883989 |
| 84 | GATA1_22025678_ChIP-Seq_K562_Human | 1.10003671 |
| 85 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.09212753 |
| 86 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.08652192 |
| 87 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.08635817 |
| 88 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.07690405 |
| 89 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07676773 |
| 90 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.06601123 |
| 91 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04477881 |
| 92 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.03870145 |
| 93 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03702351 |
| 94 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03563115 |
| 95 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.03106234 |
| 96 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03059291 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.00900910 |
| 98 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.00521023 |
| 99 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.99927008 |
| 100 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.99080543 |
| 101 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.99046829 |
| 102 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98661972 |
| 103 | GATA3_26560356_Chip-Seq_TH2_Human | 0.98268725 |
| 104 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.97291420 |
| 105 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.96255304 |
| 106 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95446695 |
| 107 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.94138452 |
| 108 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.94032817 |
| 109 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92834939 |
| 110 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.91738778 |
| 111 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91652311 |
| 112 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.91602852 |
| 113 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89571096 |
| 114 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87686647 |
| 115 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85747394 |
| 116 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.84805538 |
| 117 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84601792 |
| 118 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84527772 |
| 119 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.84283800 |
| 120 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84192405 |
| 121 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.83512054 |
| 122 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.83369734 |
| 123 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.80034858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0001835_abnormal_antigen_presentation | 4.02224549 |
| 2 | MP0005671_abnormal_response_to | 3.32497925 |
| 3 | MP0001800_abnormal_humoral_immune | 3.20577790 |
| 4 | MP0000685_abnormal_immune_system | 3.16385599 |
| 5 | MP0005387_immune_system_phenotype | 3.09610057 |
| 6 | MP0001790_abnormal_immune_system | 3.09610057 |
| 7 | MP0003436_decreased_susceptibility_to | 3.09505024 |
| 8 | MP0009785_altered_susceptibility_to | 2.95139760 |
| 9 | * MP0005000_abnormal_immune_tolerance | 2.89432238 |
| 10 | * MP0002452_abnormal_antigen_presenting | 2.86602712 |
| 11 | MP0002396_abnormal_hematopoietic_system | 2.80358578 |
| 12 | * MP0003763_abnormal_thymus_physiology | 2.77287483 |
| 13 | MP0003303_peritoneal_inflammation | 2.75823861 |
| 14 | * MP0002723_abnormal_immune_serum | 2.72520153 |
| 15 | * MP0002420_abnormal_adaptive_immunity | 2.72080770 |
| 16 | * MP0001819_abnormal_immune_cell | 2.69158506 |
| 17 | MP0005025_abnormal_response_to | 2.68011076 |
| 18 | * MP0002419_abnormal_innate_immunity | 2.60453965 |
| 19 | * MP0002398_abnormal_bone_marrow | 2.55921203 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.55838406 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.36916799 |
| 22 | * MP0000716_abnormal_immune_system | 2.29936029 |
| 23 | MP0002405_respiratory_system_inflammati | 2.21657116 |
| 24 | * MP0000689_abnormal_spleen_morphology | 2.15630450 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 2.13472366 |
| 26 | MP0006082_CNS_inflammation | 2.09021835 |
| 27 | * MP0002722_abnormal_immune_system | 2.07630607 |
| 28 | MP0004808_abnormal_hematopoietic_stem | 2.06658297 |
| 29 | MP0003724_increased_susceptibility_to | 2.03515022 |
| 30 | MP0002166_altered_tumor_susceptibility | 2.00197240 |
| 31 | * MP0002429_abnormal_blood_cell | 1.95441503 |
| 32 | MP0005174_abnormal_tail_pigmentation | 1.93956672 |
| 33 | MP0003300_gastrointestinal_ulcer | 1.92435111 |
| 34 | MP0001545_abnormal_hematopoietic_system | 1.90462748 |
| 35 | MP0005397_hematopoietic_system_phenotyp | 1.90462748 |
| 36 | MP0000465_gastrointestinal_hemorrhage | 1.89596587 |
| 37 | MP0001853_heart_inflammation | 1.87139781 |
| 38 | MP0009278_abnormal_bone_marrow | 1.85844332 |
| 39 | MP0001873_stomach_inflammation | 1.85806396 |
| 40 | * MP0010155_abnormal_intestine_physiology | 1.84250584 |
| 41 | * MP0000703_abnormal_thymus_morphology | 1.79895065 |
| 42 | * MP0001845_abnormal_inflammatory_respons | 1.74794368 |
| 43 | MP0002006_tumorigenesis | 1.73693632 |
| 44 | MP0008260_abnormal_autophagy | 1.64686307 |
| 45 | MP0003866_abnormal_defecation | 1.54402702 |
| 46 | MP0005310_abnormal_salivary_gland | 1.52289316 |
| 47 | * MP0000490_abnormal_crypts_of | 1.48707136 |
| 48 | MP0004510_myositis | 1.48194950 |
| 49 | MP0008057_abnormal_DNA_replication | 1.45795157 |
| 50 | MP0000015_abnormal_ear_pigmentation | 1.43520152 |
| 51 | MP0004947_skin_inflammation | 1.41995520 |
| 52 | MP0005075_abnormal_melanosome_morpholog | 1.41875162 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.40592125 |
| 54 | MP0003693_abnormal_embryo_hatching | 1.35859356 |
| 55 | MP0002933_joint_inflammation | 1.32958327 |
| 56 | MP0005451_abnormal_body_composition | 1.32135315 |
| 57 | MP0010094_abnormal_chromosome_stability | 1.31428145 |
| 58 | MP0000858_altered_metastatic_potential | 1.29810406 |
| 59 | MP0008469_abnormal_protein_level | 1.29303105 |
| 60 | MP0005058_abnormal_lysosome_morphology | 1.28450614 |
| 61 | MP0003172_abnormal_lysosome_physiology | 1.27984321 |
| 62 | MP0008058_abnormal_DNA_repair | 1.19801627 |
| 63 | MP0002095_abnormal_skin_pigmentation | 1.17721520 |
| 64 | MP0003448_altered_tumor_morphology | 1.17334827 |
| 65 | MP0002132_abnormal_respiratory_system | 1.10972019 |
| 66 | MP0004883_abnormal_blood_vessel | 1.10651711 |
| 67 | MP0002019_abnormal_tumor_incidence | 1.10413575 |
| 68 | MP0003077_abnormal_cell_cycle | 1.08235891 |
| 69 | MP0003111_abnormal_nucleus_morphology | 1.07573453 |
| 70 | MP0003183_abnormal_peptide_metabolism | 1.06360628 |
| 71 | MP0010307_abnormal_tumor_latency | 1.05286073 |
| 72 | MP0000343_altered_response_to | 0.97583832 |
| 73 | MP0003690_abnormal_glial_cell | 0.95321839 |
| 74 | MP0009764_decreased_sensitivity_to | 0.94336067 |
| 75 | MP0001851_eye_inflammation | 0.87947783 |
| 76 | MP0008007_abnormal_cellular_replicative | 0.87630867 |
| 77 | MP0003806_abnormal_nucleotide_metabolis | 0.87159461 |
| 78 | MP0003191_abnormal_cellular_cholesterol | 0.86736662 |
| 79 | MP0008004_abnormal_stomach_pH | 0.83340148 |
| 80 | MP0005164_abnormal_response_to | 0.83250884 |
| 81 | MP0004381_abnormal_hair_follicle | 0.77640996 |
| 82 | MP0000604_amyloidosis | 0.76813810 |
| 83 | * MP0002998_abnormal_bone_remodeling | 0.76518798 |
| 84 | MP0001986_abnormal_taste_sensitivity | 0.76489854 |
| 85 | MP0001663_abnormal_digestive_system | 0.75954339 |
| 86 | MP0000313_abnormal_cell_death | 0.75007390 |
| 87 | MP0003045_fibrosis | 0.74250285 |
| 88 | MP0002277_abnormal_respiratory_mucosa | 0.73931627 |
| 89 | MP0009840_abnormal_foam_cell | 0.69491601 |
| 90 | MP0009763_increased_sensitivity_to | 0.67634988 |
| 91 | MP0003828_pulmonary_edema | 0.65368774 |
| 92 | MP0000569_abnormal_digit_pigmentation | 0.65036790 |
| 93 | MP0002009_preneoplasia | 0.63476054 |
| 94 | MP0000371_diluted_coat_color | 0.61368589 |
| 95 | MP0008874_decreased_physiological_sensi | 0.61119619 |
| 96 | MP0005390_skeleton_phenotype | 0.61051622 |
| 97 | MP0003075_altered_response_to | 0.59928235 |
| 98 | MP0003656_abnormal_erythrocyte_physiolo | 0.59845568 |
| 99 | MP0005166_decreased_susceptibility_to | 0.55415857 |
| 100 | MP0004957_abnormal_blastocyst_morpholog | 0.54855206 |
| 101 | MP0000249_abnormal_blood_vessel | 0.54151174 |
| 102 | MP0010352_gastrointestinal_tract_polyps | 0.51582864 |
| 103 | MP0005319_abnormal_enzyme/_coenzyme | 0.51020310 |
| 104 | MP0002693_abnormal_pancreas_physiology | 0.50386511 |
| 105 | MP0006292_abnormal_olfactory_placode | 0.49699401 |
| 106 | MP0003786_premature_aging | 0.49298182 |
| 107 | * MP0003795_abnormal_bone_structure | 0.48471697 |
| 108 | MP0002138_abnormal_hepatobiliary_system | 0.48316264 |
| 109 | MP0000477_abnormal_intestine_morphology | 0.48230781 |
| 110 | MP0005381_digestive/alimentary_phenotyp | 0.48028722 |
| 111 | MP0002075_abnormal_coat/hair_pigmentati | 0.47120843 |
| 112 | MP0004130_abnormal_muscle_cell | 0.47063382 |
| 113 | MP0003943_abnormal_hepatobiliary_system | 0.46845175 |
| 114 | MP0003221_abnormal_cardiomyocyte_apopto | 0.45879022 |
| 115 | MP0000609_abnormal_liver_physiology | 0.45822134 |
| 116 | MP0002136_abnormal_kidney_physiology | 0.45518250 |
| 117 | MP0005076_abnormal_cell_differentiation | 0.45391387 |
| 118 | MP0009765_abnormal_xenobiotic_induced | 0.44932271 |
| 119 | MP0008873_increased_physiological_sensi | 0.44819847 |
| 120 | MP0005083_abnormal_biliary_tract | 0.42361743 |
| 121 | MP0002928_abnormal_bile_duct | 0.41749228 |
| 122 | MP0003091_abnormal_cell_migration | 0.40957742 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.56417795 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.19077173 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.87021320 |
| 4 | Recurrent fungal infections (HP:0002841) | 4.43328425 |
| 5 | Recurrent viral infections (HP:0004429) | 4.26960763 |
| 6 | Myositis (HP:0100614) | 4.14391010 |
| 7 | Gastrointestinal infarctions (HP:0005244) | 4.11485002 |
| 8 | Chronic otitis media (HP:0000389) | 4.05776054 |
| 9 | Cellulitis (HP:0100658) | 3.91341352 |
| 10 | * Meningitis (HP:0001287) | 3.89718867 |
| 11 | Panhypogammaglobulinemia (HP:0003139) | 3.86768758 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.81880814 |
| 13 | Agammaglobulinemia (HP:0004432) | 3.81042707 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 3.74217757 |
| 15 | Hypochromic microcytic anemia (HP:0004840) | 3.73266071 |
| 16 | Recurrent bronchitis (HP:0002837) | 3.70008974 |
| 17 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.67097296 |
| 18 | Recurrent cutaneous fungal infections (HP:0011370) | 3.67097296 |
| 19 | * IgM deficiency (HP:0002850) | 3.66343897 |
| 20 | Recurrent skin infections (HP:0001581) | 3.59981035 |
| 21 | T lymphocytopenia (HP:0005403) | 3.56227215 |
| 22 | Abnormality of macrophages (HP:0004311) | 3.46722468 |
| 23 | Abnormality of T cell number (HP:0011839) | 3.44088681 |
| 24 | * Chronic obstructive pulmonary disease (HP:0006510) | 3.41394858 |
| 25 | * Obstructive lung disease (HP:0006536) | 3.41394858 |
| 26 | Thrombocytosis (HP:0001894) | 3.37277097 |
| 27 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.30369871 |
| 28 | * Urticaria (HP:0001025) | 3.28147777 |
| 29 | Abnormality of B cell number (HP:0010975) | 3.19286844 |
| 30 | B lymphocytopenia (HP:0010976) | 3.19286844 |
| 31 | Optic neuritis (HP:0100653) | 3.15417822 |
| 32 | Retrobulbar optic neuritis (HP:0100654) | 3.15417822 |
| 33 | * Abnormality of T cells (HP:0002843) | 3.11698599 |
| 34 | Pustule (HP:0200039) | 3.10958942 |
| 35 | Episodic fever (HP:0001954) | 3.09040198 |
| 36 | * Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.06855530 |
| 37 | Orchitis (HP:0100796) | 3.05158046 |
| 38 | Stomatitis (HP:0010280) | 3.00091094 |
| 39 | * Vasculitis (HP:0002633) | 2.94886374 |
| 40 | Thyroiditis (HP:0100646) | 2.91638053 |
| 41 | IgG deficiency (HP:0004315) | 2.91522392 |
| 42 | * Prolonged bleeding time (HP:0003010) | 2.91108181 |
| 43 | Colitis (HP:0002583) | 2.87896289 |
| 44 | Nasal polyposis (HP:0100582) | 2.86851428 |
| 45 | Increased IgM level (HP:0003496) | 2.85076505 |
| 46 | * Inflammation of the large intestine (HP:0002037) | 2.83068502 |
| 47 | * Gastrointestinal inflammation (HP:0004386) | 2.78940940 |
| 48 | * Chest pain (HP:0100749) | 2.75018329 |
| 49 | Recurrent sinusitis (HP:0011108) | 2.73887077 |
| 50 | Granulocytopenia (HP:0001913) | 2.73711031 |
| 51 | Eosinophilia (HP:0001880) | 2.71158042 |
| 52 | Gingivitis (HP:0000230) | 2.70960852 |
| 53 | Anorexia (HP:0002039) | 2.69405320 |
| 54 | Recurrent pneumonia (HP:0006532) | 2.67058359 |
| 55 | Osteomyelitis (HP:0002754) | 2.65810695 |
| 56 | Severe combined immunodeficiency (HP:0004430) | 2.65089751 |
| 57 | * Abnormality of T cell physiology (HP:0011840) | 2.64614697 |
| 58 | Leukocytosis (HP:0001974) | 2.63367515 |
| 59 | * Petechiae (HP:0000967) | 2.61441484 |
| 60 | Vacuolated lymphocytes (HP:0001922) | 2.59488617 |
| 61 | * Lymphopenia (HP:0001888) | 2.58411513 |
| 62 | Abnormality of the fingertips (HP:0001211) | 2.56894660 |
| 63 | Amyloidosis (HP:0011034) | 2.52506430 |
| 64 | * Hypochromic anemia (HP:0001931) | 2.52232043 |
| 65 | * Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.51992397 |
| 66 | Abnormality of the nasal mucosa (HP:0000433) | 2.50684669 |
| 67 | Abnormality of the prostate (HP:0008775) | 2.48575938 |
| 68 | Verrucae (HP:0200043) | 2.47550771 |
| 69 | Papilloma (HP:0012740) | 2.47550771 |
| 70 | Combined immunodeficiency (HP:0005387) | 2.46586697 |
| 71 | Gastrointestinal stroma tumor (HP:0100723) | 2.46493422 |
| 72 | Abnormality of eosinophils (HP:0001879) | 2.46146941 |
| 73 | Chronic sinusitis (HP:0011109) | 2.45715119 |
| 74 | Autoimmune thrombocytopenia (HP:0001973) | 2.45280692 |
| 75 | * Epistaxis (HP:0000421) | 2.45229952 |
| 76 | Abnormality of the pleura (HP:0002103) | 2.43015086 |
| 77 | * Lymphoma (HP:0002665) | 2.37462138 |
| 78 | Pulmonary infiltrates (HP:0002113) | 2.37382146 |
| 79 | Impaired platelet aggregation (HP:0003540) | 2.36684857 |
| 80 | Abnormal platelet function (HP:0011869) | 2.36684857 |
| 81 | Reticulocytopenia (HP:0001896) | 2.36038822 |
| 82 | Periodontitis (HP:0000704) | 2.34951154 |
| 83 | Chromsome breakage (HP:0040012) | 2.34515770 |
| 84 | Peritonitis (HP:0002586) | 2.32906515 |
| 85 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.32526323 |
| 86 | * Encephalitis (HP:0002383) | 2.31304572 |
| 87 | Hemoptysis (HP:0002105) | 2.31112390 |
| 88 | Arterial thrombosis (HP:0004420) | 2.30924478 |
| 89 | IgA deficiency (HP:0002720) | 2.30733885 |
| 90 | Gangrene (HP:0100758) | 2.29406938 |
| 91 | Abnormal number of erythroid precursors (HP:0012131) | 2.27517841 |
| 92 | Chronic diarrhea (HP:0002028) | 2.26970010 |
| 93 | Premature loss of primary teeth (HP:0006323) | 2.24530091 |
| 94 | * Spontaneous hematomas (HP:0007420) | 2.24383819 |
| 95 | * Pulmonary embolism (HP:0002204) | 2.23955753 |
| 96 | Hepatosplenomegaly (HP:0001433) | 2.22625301 |
| 97 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.22103706 |
| 98 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.22083579 |
| 99 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.22083579 |
| 100 | Abnormality of glycolipid metabolism (HP:0010969) | 2.22083579 |
| 101 | * Increased IgE level (HP:0003212) | 2.20969277 |
| 102 | * Recurrent lower respiratory tract infections (HP:0002783) | 2.18801742 |
| 103 | Increased serum ferritin (HP:0003281) | 2.18056196 |
| 104 | Abnormality of the peritoneum (HP:0002585) | 2.17994168 |
| 105 | Loss of speech (HP:0002371) | 2.17530073 |
| 106 | Keratoconjunctivitis sicca (HP:0001097) | 2.15406813 |
| 107 | Myelodysplasia (HP:0002863) | 2.14370642 |
| 108 | Cheilitis (HP:0100825) | 2.13865687 |
| 109 | Autoimmune hemolytic anemia (HP:0001890) | 2.13765505 |
| 110 | Basal ganglia calcification (HP:0002135) | 2.13635033 |
| 111 | Restrictive lung disease (HP:0002091) | 2.10742323 |
| 112 | Albinism (HP:0001022) | 2.09934791 |
| 113 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.09700811 |
| 114 | Leukopenia (HP:0001882) | 2.08479227 |
| 115 | Interstitial pulmonary disease (HP:0006530) | 2.07139374 |
| 116 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.06031688 |
| 117 | Abnormality of the endocardium (HP:0004306) | 2.05825331 |
| 118 | * Gingival bleeding (HP:0000225) | 2.05148462 |
| 119 | * Sepsis (HP:0100806) | 2.04900299 |
| 120 | Clubbing of toes (HP:0100760) | 2.04688287 |
| 121 | Abnormality of iron homeostasis (HP:0011031) | 2.04523376 |
| 122 | Increased cerebral lipofuscin (HP:0011813) | 2.04339798 |
| 123 | Viral hepatitis (HP:0006562) | 2.03911660 |
| 124 | Skin rash (HP:0000988) | 2.03127889 |
| 125 | Agnosia (HP:0010524) | 2.02723195 |
| 126 | Slow saccadic eye movements (HP:0000514) | 2.02058936 |
| 127 | Bronchitis (HP:0012387) | 2.00884215 |
| 128 | * Skin ulcer (HP:0200042) | 2.00177855 |
| 129 | * Hypergammaglobulinemia (HP:0010702) | 1.97815098 |
| 130 | Acne (HP:0001061) | 1.97482701 |
| 131 | Aplastic anemia (HP:0001915) | 1.96548245 |
| 132 | Abnormality of the pericardium (HP:0001697) | 1.96247169 |
| 133 | Keratoconjunctivitis (HP:0001096) | 1.94686629 |
| 134 | Arthralgia (HP:0002829) | 1.94107908 |
| 135 | Prostate neoplasm (HP:0100787) | 1.93833390 |
| 136 | * Microcytic anemia (HP:0001935) | 1.93399253 |
| 137 | Polyneuropathy (HP:0001271) | 1.92664970 |
| 138 | Vertigo (HP:0002321) | 1.91879034 |
| 139 | Abnormality of DNA repair (HP:0003254) | 1.91712163 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.83974582 |
| 2 | TXK | 3.20533045 |
| 3 | IRAK4 | 3.07560204 |
| 4 | BLK | 3.02968648 |
| 5 | PRPF4B | 2.60670691 |
| 6 | TYK2 | 2.34578864 |
| 7 | JAK3 | 2.21479302 |
| 8 | TEC | 2.20975330 |
| 9 | ZAP70 | 2.19205557 |
| 10 | IRAK3 | 2.16944188 |
| 11 | KIT | 2.12568949 |
| 12 | GRK6 | 2.07734900 |
| 13 | * BTK | 2.05013708 |
| 14 | MAP3K14 | 2.04004538 |
| 15 | EEF2K | 1.96498908 |
| 16 | SYK | 1.93560622 |
| 17 | IKBKE | 1.92789640 |
| 18 | STK10 | 1.92254388 |
| 19 | CSF1R | 1.83925275 |
| 20 | TAOK1 | 1.77085474 |
| 21 | MAP3K11 | 1.74789185 |
| 22 | CLK1 | 1.71756714 |
| 23 | TBK1 | 1.71420718 |
| 24 | FES | 1.71255512 |
| 25 | MAP3K10 | 1.65691740 |
| 26 | MAP3K3 | 1.62450884 |
| 27 | RIPK4 | 1.56659581 |
| 28 | ITK | 1.54649050 |
| 29 | IKBKB | 1.50793282 |
| 30 | CSK | 1.47831175 |
| 31 | PIM1 | 1.44413766 |
| 32 | * LCK | 1.38673555 |
| 33 | TGFBR2 | 1.38285379 |
| 34 | NME2 | 1.38113795 |
| 35 | JAK1 | 1.36566332 |
| 36 | * HCK | 1.36427990 |
| 37 | * LYN | 1.30374650 |
| 38 | TAOK3 | 1.25419083 |
| 39 | MAP2K3 | 1.22707405 |
| 40 | MAP3K1 | 1.21216368 |
| 41 | SIK2 | 1.17336595 |
| 42 | SMG1 | 1.16774390 |
| 43 | ERN1 | 1.16404049 |
| 44 | TRIB3 | 1.15047797 |
| 45 | NLK | 1.12872354 |
| 46 | PIM2 | 1.07472358 |
| 47 | LRRK2 | 1.04680566 |
| 48 | KSR2 | 1.02336244 |
| 49 | TAOK2 | 0.99692496 |
| 50 | CDK12 | 0.97211711 |
| 51 | MARK2 | 0.97112557 |
| 52 | MST4 | 0.93845372 |
| 53 | STK4 | 0.92133482 |
| 54 | FGFR3 | 0.92069947 |
| 55 | PDK1 | 0.91147367 |
| 56 | SIK3 | 0.86401302 |
| 57 | CDK4 | 0.85860911 |
| 58 | STK16 | 0.84699046 |
| 59 | RPS6KA4 | 0.84637197 |
| 60 | EPHB1 | 0.83569985 |
| 61 | CDK19 | 0.81396927 |
| 62 | CHUK | 0.80723426 |
| 63 | NEK2 | 0.78270994 |
| 64 | FGFR4 | 0.78129442 |
| 65 | MAPK12 | 0.77904654 |
| 66 | BMPR2 | 0.77868777 |
| 67 | MARK3 | 0.77655106 |
| 68 | YES1 | 0.77332810 |
| 69 | KDR | 0.75142718 |
| 70 | PDPK1 | 0.73471288 |
| 71 | PKN2 | 0.73212392 |
| 72 | CDC7 | 0.72335314 |
| 73 | CDC42BPA | 0.71691199 |
| 74 | HIPK2 | 0.71565274 |
| 75 | JAK2 | 0.71445120 |
| 76 | MAP3K7 | 0.70475445 |
| 77 | IRAK2 | 0.69214344 |
| 78 | MATK | 0.68508855 |
| 79 | MAPK7 | 0.68101649 |
| 80 | ATR | 0.67083468 |
| 81 | MKNK1 | 0.65308725 |
| 82 | VRK1 | 0.64312980 |
| 83 | TRPM7 | 0.63259372 |
| 84 | SIK1 | 0.62137913 |
| 85 | EIF2AK3 | 0.62091694 |
| 86 | BRD4 | 0.61636192 |
| 87 | PRKCQ | 0.59953409 |
| 88 | MAP3K13 | 0.59223978 |
| 89 | MAPK4 | 0.58951037 |
| 90 | RPS6KA6 | 0.57609369 |
| 91 | * FYN | 0.56917449 |
| 92 | MKNK2 | 0.55489364 |
| 93 | FLT3 | 0.54973334 |
| 94 | ADRBK2 | 0.52719904 |
| 95 | MAP3K6 | 0.52363497 |
| 96 | STK24 | 0.49862674 |
| 97 | ZAK | 0.49581732 |
| 98 | TGFBR1 | 0.49474564 |
| 99 | ALK | 0.49463482 |
| 100 | STK11 | 0.49351210 |
| 101 | CAMKK1 | 0.49249205 |
| 102 | IRAK1 | 0.48900637 |
| 103 | RPS6KC1 | 0.48809127 |
| 104 | RPS6KL1 | 0.48809127 |
| 105 | MAP2K2 | 0.48300517 |
| 106 | CDK7 | 0.48127779 |
| 107 | RPS6KA5 | 0.47086544 |
| 108 | DYRK1B | 0.47062617 |
| 109 | CDK9 | 0.46369495 |
| 110 | RPS6KB2 | 0.45840753 |
| 111 | MAPKAPK2 | 0.45406709 |
| 112 | EIF2AK2 | 0.44928544 |
| 113 | PASK | 0.44324337 |
| 114 | CDK6 | 0.43779579 |
| 115 | GRK7 | 0.43397963 |
| 116 | EPHA3 | 0.42878008 |
| 117 | MAP3K5 | 0.41415188 |
| 118 | MAPK11 | 0.40263474 |
| 119 | FGR | 0.39063627 |
| 120 | PIK3CG | 0.39027479 |
| 121 | TESK2 | 0.38391366 |
| 122 | PTK2B | 0.37707805 |
| 123 | RET | 0.37103745 |
| 124 | PLK4 | 0.36757952 |
| 125 | MAP2K6 | 0.36619109 |
| 126 | SRPK1 | 0.36325539 |
| 127 | PRKCD | 0.35832604 |
| 128 | CAMKK2 | 0.35631944 |
| 129 | PRKD2 | 0.35440208 |
| 130 | SGK3 | 0.35250538 |
| 131 | PRKCH | 0.35084157 |
| 132 | TSSK6 | 0.34822979 |
| 133 | MAP2K4 | 0.34322593 |
| 134 | NUAK1 | 0.33862161 |
| 135 | PTK6 | 0.33389600 |
| 136 | MAP3K8 | 0.31609181 |
| 137 | * TNK2 | 0.31264915 |
| 138 | RAF1 | 0.29528207 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.53302907 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.64208260 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.44211310 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.43720453 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.37721186 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.30715702 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 2.26878808 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.26298898 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.15742334 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.06910267 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.06669619 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.06369488 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.94310053 |
| 14 | Ribosome_Homo sapiens_hsa03010 | 1.78648623 |
| 15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.73111880 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.72746536 |
| 17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.71572396 |
| 18 | Mismatch repair_Homo sapiens_hsa03430 | 1.70187541 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.69971586 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.67345109 |
| 21 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.64348868 |
| 22 | Other glycan degradation_Homo sapiens_hsa00511 | 1.62610610 |
| 23 | Base excision repair_Homo sapiens_hsa03410 | 1.58830090 |
| 24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.53684381 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.53602266 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.49800440 |
| 27 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.46959629 |
| 28 | Asthma_Homo sapiens_hsa05310 | 1.45158941 |
| 29 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.44113253 |
| 30 | Homologous recombination_Homo sapiens_hsa03440 | 1.40279530 |
| 31 | Legionellosis_Homo sapiens_hsa05134 | 1.36920543 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.35317513 |
| 33 | Pertussis_Homo sapiens_hsa05133 | 1.32480518 |
| 34 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.32311856 |
| 35 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.29554753 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 1.28969031 |
| 37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.28079365 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.27459215 |
| 39 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.25172182 |
| 40 | Hepatitis B_Homo sapiens_hsa05161 | 1.22253941 |
| 41 | Malaria_Homo sapiens_hsa05144 | 1.21777379 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.21268179 |
| 43 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.20281935 |
| 44 | Spliceosome_Homo sapiens_hsa03040 | 1.18274474 |
| 45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.15592004 |
| 46 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.13953843 |
| 47 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.13715412 |
| 48 | * Shigellosis_Homo sapiens_hsa05131 | 1.12347950 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.09684069 |
| 50 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.06600228 |
| 51 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.03613574 |
| 52 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.02737394 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 0.98491211 |
| 54 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.98191696 |
| 55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94581296 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.93096281 |
| 57 | Viral myocarditis_Homo sapiens_hsa05416 | 0.89172380 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.88598873 |
| 59 | * Salmonella infection_Homo sapiens_hsa05132 | 0.84945227 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84596179 |
| 61 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.83112832 |
| 62 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82675427 |
| 63 | Lysosome_Homo sapiens_hsa04142 | 0.80408039 |
| 64 | HTLV-I infection_Homo sapiens_hsa05166 | 0.76996298 |
| 65 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.76952085 |
| 66 | Cell cycle_Homo sapiens_hsa04110 | 0.76923195 |
| 67 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.72823995 |
| 68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.70599922 |
| 69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70471125 |
| 70 | Hepatitis C_Homo sapiens_hsa05160 | 0.70285982 |
| 71 | RNA degradation_Homo sapiens_hsa03018 | 0.70232561 |
| 72 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.69785236 |
| 73 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.68820188 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68089494 |
| 75 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.66692146 |
| 76 | * Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.66551554 |
| 77 | * Endocytosis_Homo sapiens_hsa04144 | 0.65533209 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61758545 |
| 79 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.61356145 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.61112190 |
| 81 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.59150700 |
| 82 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.58951761 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58223107 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58075980 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56515416 |
| 86 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55738912 |
| 87 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.55487296 |
| 88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.54266237 |
| 89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51999146 |
| 90 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50306552 |
| 91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48851438 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48689628 |
| 93 | RNA polymerase_Homo sapiens_hsa03020 | 0.48446123 |
| 94 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.48097907 |
| 95 | Colorectal cancer_Homo sapiens_hsa05210 | 0.47432319 |
| 96 | RNA transport_Homo sapiens_hsa03013 | 0.47279041 |
| 97 | Phagosome_Homo sapiens_hsa04145 | 0.46915230 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | 0.46904818 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46350932 |
| 100 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.45156185 |
| 101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44553085 |
| 102 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.43217539 |
| 103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42890736 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41598985 |
| 105 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.41080279 |
| 106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.40599560 |
| 107 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40100002 |
| 108 | Insulin resistance_Homo sapiens_hsa04931 | 0.40011118 |
| 109 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.39842956 |
| 110 | Basal transcription factors_Homo sapiens_hsa03022 | 0.39677147 |
| 111 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38864631 |
| 112 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38112811 |
| 113 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37235752 |
| 114 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37013211 |
| 115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36354091 |
| 116 | Proteasome_Homo sapiens_hsa03050 | 0.35289570 |
| 117 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35029856 |
| 118 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34596838 |
| 119 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.34331173 |
| 120 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.30338739 |
| 121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29903414 |
| 122 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.29505410 |
| 123 | Prostate cancer_Homo sapiens_hsa05215 | 0.29323948 |
| 124 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.28773357 |
| 125 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.27672444 |
| 126 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.27212000 |
| 127 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.23848015 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.21506227 |

